Evaluation of immunohistochemical staining of securin and Ki-67 in invasive breast carcinoma using the semiquantitative method and immune ratio: a comparative study
Conclusion
These results suggest that securin may have value superior to Ki-67 in identifying invasive breast carcinoma patients with poor clinical outcome.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: ORIGINAL ARTICLES Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Egypt Health | Pathology | Study